Chemical in brain acts like a fuel gauge

The concept that a drop in blood sugar triggers a craving for food is best understood just before lunchtime. But exactly how the process unfolds has proven difficult to explain, even on a full stomach.

Solving the puzzle would yield new insights in the fight against diabetes. Neuroscientists at the University of Southern California provide a partial answer in the July 4 issue of The Journal of Neuroscience.

Their study, highlighted by the journal on its news page, identifies a chemical that sends a “low blood sugar” message to a part of the brain that can do something about it.

The neurotransmitter norepinephrine travels from the hindbrain, which receives warnings of low glucose levels from the body, to the paraventricular hypothalamus, which authorizes the consumption of energy stores to replace the missing sugars.

The energy stores help for a while, but the end result is a feeling that the body is running on empty. Lunch, anyone"

While the study has few near-term clinical implications, except perhaps for diabetics with low blood sugar (hypoglycemia) from insulin overdoses, it is of fundamental interest in the field.

“There’s a huge interest in how the body senses glucose,” said Alan Watts, director of the Neuroscience Research Institute at USC and a co-author of the study.

“How that information is processed by the brain is really a hot current topic.”

Knowing how neurons relay hypoglycemia warnings is critical to understanding the overall glucose sensing mechanism in the brain, added corresponding author Arshad Khan, a research assistant professor at USC.

“That’s why I’m interested in this system, because it’s very poorly understood,” Khan said.

“If we don’t know how an automobile’s fuel system works to begin with, then how can we expect to fix one when it is not burning fuel appropriately"”

In his study, Khan injected insulin in a group of animals to drop their blood sugar levels. In another group, he injected norepinephrine directly into the paraventricular nucleus.

Khan then compared brain tissue sections from both groups of animals and also examined blood samples for the presence of hormones released by paraventricular nucleus activity.

The same paraventricular neurons lit up in both sets of animals, and the animals displayed similar increases in hormone levels, suggesting that norepinephrine plays a role in transmitting the hypoglycemia warning.

“Norepinephrine is capable of activating these signals just like hypoglycemia does,” Khan said.

Khan then confirmed his findings with analogous experiments in vitro carried out in collaboration with neuroscientists at the University of California, Riverside.

Additional results from an ongoing study suggest that norepinephrine is not only sufficient but necessary for conveying hypoglycemia signals from the hindbrain, Khan added.

The current study, funded by the National Institute of Mental Health and the National Institute of Neurological Disorders and Stroke, was inspired by earlier work published in the journal Endocrinology by Sue Ritter of Washington State University.

In her studies, one of which was co-authored by Watts, Ritter showed that hypoglycemic animals lost their feeding and hormonal responses to hypoglycemia after damage to the norepinephrine pathways connecting the hindbrain to the hypothalamus.

Source: University of Southern California

Related stories:

Study identifies factors associated with poor weight loss after gastric bypass surgery
Individuals with diabetes and those whose stomach pouches are larger appear less likely to successfully lose weight after gastric bypass surgery, according to a report in the September issue of Archives of Surgery.
Findings challenge common practice regarding glucose control for critically ill patients
An analysis of randomized trials indicates that for critically ill adults, tight glucose control is not associated with a significantly reduced risk of death in the hospital, but is associated with an increased risk of hypoglycemia, calling into question the recommendation by many professional societies for tight glucose control for these patients, according to an article in the August 27 issue of JAMA.
Treatment corrects severe insulin imbalance in animal studies
Researchers have used a drug to achieve normal levels of blood sugar in animals genetically engineered to have abnormally high insulin levels. If this approach succeeds in humans, it could become an innovative medicine for children with congenital hyperinsulinism, a rare but potentially devastating genetic disease in which insulin levels become dangerously high.
Daily walk can help control diabetes
(PhysOrg.com) -- Just an extra 45 minute walk a day can help people control Type 2 diabetes, according to a new study at Newcastle University. Dr Michael Trenell and Prof Roy Taylor, who led the research, showed that people with Type 2 diabetes who walk regularly can keep some of the effects of the disease at bay.
Study shows intensive glucose control reduces serious complications
An Australian led global study, the largest of its kind, has found that the risk of developing serious kidney disease and other complications amongst our 1.2 million people living with diabetes can be significantly reduced by intensively lowering blood glucose (sugar) levels beyond what is currently standard practice.
Studies test new approaches to islet transplantation
Researchers from 11 medical centers in the United States, Canada, Sweden, and Norway have begun testing new approaches to transplanting clusters of insulin-producing islets in adults with difficult-to-control type 1 diabetes. The clinical studies, funded by the National Institutes of Health (NIH), will determine whether changes to current methods of islet transplantation lead to improved, long-lasting control of blood glucose with fewer side effects.
Bypassing the insulin highway
An immune cell known as a neutrophil releases a protein that can suppress glucose production in the liver –without targeting insulin, researchers have found.
Survey offers first-ever look at treatment practices for nonepileptic seizures
A new nationwide clinician survey provides the first comprehensive look at what is community care or ‘treatment as usual’ for nonepileptic seizures (NES), laying the groundwork for clinical trials aimed at identifying effective treatments for this neuropsychiatric disorder.

News discussion:

Medicine & Health news